Global Anesthesia and Respiratory Devices Market 2026 – 2035

The market size of the global anesthesia and respiratory devices will be estimated at USD 57.2 billion in 2025 and is expected to grow to between USD 60.5 billion in 2026 and about USD 100.5 billion by 2035 with a current CAGR of 5.8% during the period of 2026 to 2035. Anesthesia and respiratory devices market is primarily driven by the global rise in respiratory problems and surgical operations.

The respiratory support appliances, such as ventilators, oxygen concentrators, nebulizers, and positive airway pressure systems, are mainly driven by chronic diseases like chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and other lung disorders, which are at the forefront of the demand. The gradually increasing number of surgical procedures is the other major factor that warrants a large demand for anesthesia machines, airway management devices, and monitoring systems, which are indirectly supported by improved healthcare access, higher prevalence of lifestyle-related diseases, trauma cases, and elective surgeries. Another contributing factor for the market growth is the rapid rise of the elderly population since the aged ones are more prone to getting respiratory diseases and needing surgery.

Market Highlight

• North America had a market share of 30% as a market leader in the anesthesia and respiratory devices market in 2025.

• The Asia Pacific is expected to grow at the highest CAGR during the years 2026-2035.

• By product, the respiratory devices segment dominates the market with over 55% in 2025.

• By end user, the hospitals segment is expected to capture the substantial market share over the forecast period.

Significant Growth Factors

The anesthesia and respiratory devices market trends present significant growth opportunities due to several factors:

• Rising Prevalence of Respiratory Diseases:

The global anesthesia and respiratory devices market is mainly fueled by the increasing occurrence of respiratory diseases as the global burden of diseases like chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and other chronic and acute pulmonary disorders continues to rise. The declination of smoking, the exposure of workers to dangerous substances, and the lack of physical activity are the main reasons that have greatly increased the number of people suffering from respiratory illnesses around the globe. Consequently, the demand for respiratory care solutions such as ventilators, Oxygen Therapy Devices, nebulizers, and Positive Airway Pressure Systems across hospitals, clinics, and home care settings is sustained and growing. Moreover, patients with serious respiratory disorders frequently need surgical treatment or critical care; hence, there is even more demand for advanced anesthesia delivery and airway management devices that would ensure patient safety during procedures.

The combination of the ever-increasing number of patients, the need for long-term respiratory management, and the need for acute care support continues to be a strong force in driving the growth of the anesthesia and respiratory devices market. For instance, according to the European Respiratory Society, The number of people suffering from COPD is estimated to reach about 645.6 million by the year 2050, which would mean a 36% increase in the global prevalence of the disease when compared to 2020 figures. In other words, the agency's projections say that there will be around 454.4 million men and 191.2 million women who will have COPD. There is still a long way to go before the problem of COPD in high-income countries will be over, as the latter are toying with the highest prevalence rates, but that will not come easy, as the rising trend in the case of the disease in lower-middle income countries (e.g., Sub-Saharan Africa, South Asia) has made a big impact on the overall picture. Furthermore, although the male COPD prevalence in low- and high-income countries is predicted to be 13.8% vs. 16.9%, there will be more than twice as many patients with COPD in low- compared to high-income countries. This applies also to female COPD projections, where similar trends are expected.

• Expansion of Home Healthcare and Ambulatory Services:

The growth of home healthcare and ambulatory services is one of the major factors affecting the anesthesia and respiratory devices market, as healthcare systems are switching to patient-centered and cost-effective care models by reducing hospital stays. The introduction of user-friendly and portable respiratory devices such as home ventilators, oxygen concentrators, CPAP and BiPAP systems, and nebulizers has completely transformed the management of chronic respiratory conditions at home. This trend is unstoppable as there are more and more old-aged people, respiratory diseases that last for a long time becoming common, and patients prefer to be treated in places they are used to. Apart from this, the rapid emergence of ambulatory surgical centers has been a significant factor in the demand for small, efficient sterilization and airway management devices that can be used in outpatient surgeries. Overall, the trend of at-home care and ambulatory services is making the use of anesthesia and respiratory devices wider, spreading not only to the hospitals but also to the patients' homes, which in turn is continuously driving the market growth.

What are the Major Advances Changing the Anesthesia and Respiratory Devices Market Today?

• Portable and Home-Use Systems: Nowadays, portable and home-use systems are deemed to be the leading factor that is changing the market of anesthesia and respiratory devices in a major way. At the same time, the strong drive toward cutting down the sizes of devices, making batteries more efficient, and better digital integration resulted in lightweight, compact, and easy-to-use respiratory devices. These include portable ventilators, oxygen concentrators, CPAP and BiPAP machines, and nebulizers, which are suitable for use outside hospitals. These systems help chronic respiratory patients like those with COPD and sleep apnea to manage their condition at home and reduce their dependence on inpatient care. What’s more, after the pandemic, which raised the demand for home healthcare, the patient's preference for that which is comfortable and familiar and high healthcare costs have all been reasons for the accelerated adoption of these devices. Also, a majority of the portable devices now have smart monitoring, connectivity, and safety alarm features, which allow the clinicians to monitor the patients' status from a distance and ensure the adherence to therapy. Therefore, portable and home-use systems are not only transforming care delivery models but also improving patient quality of life and significantly contributing to the growth of the anesthesia and respiratory devices market.

• Advanced Ventilation Technologies: The anesthesia and respiratory devices market is being reshaped largely by the Advanced ventilation technologies, which have significantly improved clinical outcomes, patient safety, and care efficiency. Modern ventilators now come with adaptive and intelligent ventilation modes capable of changing airflow, pressure, and oxygen delivery automatically according to a patient's respiratory mechanics and physiological needs in real-time. Cutting-edge technologies back up lung-protective ventilation strategies, reducing the risk of ventilator-induced lung injury in critically ill patients. Automated weaning systems and closed-loop ventilation consequently improve care by taking down ventilatory support slowly as patients heal, thus preventing complications and quickening hospital discharge. In anesthesia situations, advanced ventilation systems that are part of anesthesia workstations give doctors control of respiratory parameters during surgery with precision, making sure that there is stable ventilation even in high-risk or complicated surgeries. All these innovations are responsible for the increased utilization of high-end ventilation solutions in intensive care units, operating rooms, and emergency care, thus driving the growth of the anesthesia and respiratory devices market.

Category Wise Insights

By Product

Why Respiratory Devices Lead the Market?

The respiratory devices segment dominates the market with over 55% in 2025. The increasing collaboration in the market is a major reason for the industry development. For instance, in January 2025, Inspira Technologies OXY B.H.N. Ltd., being a forerunner in the technological innovation of life-support systems, made an announcement that it partnered with Zriha Medical Ltd., a renowned global manufacturer who specializes in medical devices, to set up a dedicated production line for a key element of its revolutionary ventilator support system. This partnership is about the production of a flow mechanism that will be used in Inspira's products for blood circulation outside the body during the process of oxygenation.

The anesthesia devices segment is expected to grow at the highest CAGR over the projected period. The primary reason for the growth is the rising number of surgeries, both elective and emergency. Thus, there has been an increased demand for advanced anesthesia workstations and delivery systems in hospitals and outpatient surgery centers. Furthermore, the rising incidence of chronic diseases such as heart problems, cancer, and orthopedic issues, particularly among the elderly, is resulting in more surgeries and thus, more anesthesia devices being used.

By End User

Why Hospitals Dominates the Anesthesia and Respiratory Devices Market?

The hospitals segment is expected to capture the substantial market share over the forecast period. The anesthesia and respiratory devices market is basically controlled by hospitals, which most of the time are the main places where the advanced respiratory support and anesthesia systems are needed for performing complex medical procedures, giving critical care, and emergency treatment. The majority of hospital surgeries, which can be general and orthopedic or cardiovascular and neurological interventions, are done in operating rooms, where anesthesia machines, airway management devices, and patient monitoring systems are all indispensable. Hospitals not only do surgeries but also have a very large number of seriously ill patients in ICUs who are given continuous mechanical ventilation, oxygen therapy, and advanced respiratory monitoring.

The presence of qualified anesthesiologists, pulmonologists, and respiratory therapists is one of the reasons why the devices are largely used in hospital settings; it is also the support to the availability of those operating in the hospitals. Besides, hospitals systematically have the benefit of being the preferred places where high-cost, state-of -the-art systems are invested in, tech that integrates real-time monitoring, safety alarms, and electronic health records. The hospitals that have strong reimbursement structures and regulatory compliance and the need for immediate access to life-saving equipment solutions thus prefer the advanced anesthesia and respiratory devices, even when they are able to maintain their leading position in the market with the growing home healthcare and ambulatory services trends.

The ambulatory service centers segment is expected to grow at the highest rate over the projected period. The increase in revenue is attributed to the global transition towards outpatient and same-day surgical care. Ambulatory service centers are becoming more and more the first choice for elective and minimally invasive surgery due to the fact that they also have lower treatment costs, shorter hospital stays, and quicker patient recovery times. This change has been the reason for the increasing need for small, effective, and affordable anesthesia machines, ventilators, airway management devices, and respiratory monitoring systems that are specially designed for the outpatient environment. Besides, the technology developments, such as portable anesthesia workstations, integrated ventilation systems, and user-friendly interfaces, have made it possible for ASCs to safely do a wide range of procedures without relying on large hospital infrastructure.

The influence of growing surgical volumes in the areas of orthopedics, ophthalmology, gastroenterology, and plastics, also the favorable reimbursement policies, and increasingly the patient preference for outpatient care are factors that combined lead to the growth of device adoption in ambulatory settings. Consequently, ambulatory service centers are gradually becoming a high-growth end-user segment that is drastically boosting the total revenue source in the anesthesia and respiratory devices market.

Report Scope

Regional Analysis

How Big is the North America Anesthesia and Respiratory Devices Market Size?

Its market size, in terms of North America anesthesia and respiratory devices, is projected to be USD 17.1 billion in 2025 with a growth of about USD 26.8 billion in 2035 with a CAGR of 4.6% between 2026 and 2035.

Why did North America Dominate the Anesthesia and Respiratory Devices Market in 2025?

In 2025, North America will dominate the global market with an estimated market share of 30%. The expansion owes its roots to the advanced healthcare infrastructure, volume of procedures, and fast switchover to the latest medical technologies, which are the main drivers of the market growth. Besides, the region copes with a huge burden of chronic respiratory diseases like COPD, asthma, and sleep apnea, which is mostly due to the aging of the population, poor lifestyle, and bad environmental conditions, thus maintaining the demand for respiratory products like ventilators, oxygen therapy equipment, and non-invasive devices, which is quite strong. For instance, as per the data published by the Asthma and Allergy Foundation of America, over 28 million people in the U.S. have asthma. This equals about 1 in 12 people. Also, North America is where a very high number of surgeries take place annually, and it is made possible by the backing of well-established hospital networks and a steadily increasing number of outpatient surgery centers, consequently enhancing the demand for anesthetic machines, airway management devices, and integrated monitoring systems.

U.S. Anesthesia and Respiratory Devices Market Trends

The anesthesia and respiratory devices market in the U.S. is experiencing sustained revenue growth due to the combination of various factors such as high healthcare expenditure, cutting-edge medical infrastructure, and a large patient population that necessitates surgical and respiratory treatments. In addition, the favorable reimbursement policies, the solid presence of top medical device manufacturers, and the increasing trend towards home healthcare and outpatient treatment models are all contributing to the continuous growth of the anesthesia and respiratory devices market in the U.S. together.

Why is Asia Pacific Experiencing the Fastest Growth in the Anesthesia and Respiratory Devices Market?

Asia Pacific is the main region with the fastest growth in the anesthesia and respiratory devices market ranking that can be attributed to the combination of the rapid development of healthcare infrastructures, the presence of a large and growing patient population, and the rise in investments in the healthcare sector in emerging markets such as China, India, and Southeast Asian countries. Moreover, the region is suffering from the high and increasing prevalence of respiratory diseases which are mainly caused by the toxic air, smoking, and the growth of the older population. Consequently, there is a strong demand for devices such as ventilators, oxygen therapy systems, and non-invasive respiratory devices. At the same time, improving access to healthcare and increasing awareness are causing the number of surgical procedures to rise sharply, which in turn stimulates the demand for anesthesia machines, airway management devices, and patient monitoring systems. The government is also playing a crucial role in strengthening healthcare systems by expanding hospital capacity and increasing health insurance coverage, thus contributing to the growth of the market.

India Anesthesia and Respiratory Devices Market Trends

The Indian market has an extremely fast-growing market. The growing number of product launches by the key market players are expected to flourish the market growth over the analysis period. For instance, in November 2024, In India, AstraZeneca Pharma India Limited plans to release Breztri Aerosphere in January 2025. The application of Breztri Aerosphere is for maintenance therapy to reduce symptoms and prevent issues in adult patients suffering from chronic obstructive pulmonary disease (COPD). The import and marketing permission for the inhalation preparations of Budesonide Ph. Eur 160 mcg + Glycopyrronium Ph. Eur 7.2 mcg + Formoterol Fumarate Dihydrate Ph. Eur 5 mcg (Breztri Aerosphere) in the dosage form of inhalation was granted to the company by the Drugs Controller General of India in the month of December 2023, as Form CT-20.

Why is Europe is growing at a significant rate in the Anesthesia and Respiratory Devices Market?

Europe holds a significant market share over the projected period. The strong healthcare system of the area and its inclination towards innovation are the main reasons for the stepping up of modern mechanical ventilators. Furthermore, the old European population is causing an increase in the number of patients suffering from respiratory illnesses and chronic obstructive pulmonary disease (COPD); thus, more support through ventilators is being sought. For example, Eurostat anticipates that in 2050, Europe will almost have 500,000 centenarians, with the average age going up by 4.5 years to 48.2 years.

UK Anesthesia and Respiratory Devices Market Trends

The UK holds the dominant position in the Europe market. The growing product approval is expected to flourish the market growth in the area. For instance, in May 2025, AstraZeneca's Trixeo Aerosphere (a combination of budesonide, glycopyrronium, and formoterol fumarate or BGF), which had previously been approved for treating chronic obstructive pulmonary disease (COPD) in adults, received a new license for the UK market, this time with a revolutionary, next-generation propellant that has an almost negligible Global Warming Potential (GWP). This is the first drug that is administered through a pMDI (pressurized metered dose inhaler) that is approved with the propellant, which has 99.9% lower GWP compared to the propellants that are used in the currently available pMDIs.

Why is the Middle East & Africa Region is growing rapidly in the Anesthesia and Respiratory Devices?

The MEA region is growing at a steady rate over the projected period. The anesthesia and respiratory devices market in the MEA region is slowly but surely increasing its revenue, mainly due to the betterment of healthcare facilities, more funds being allocated to the building of hospitals, and people being more informed about the latest medical technologies. Different Middle Eastern nations, first of all those in the GCC, are pouring money into building new hospitals, upgrading ICUs, and equipping the operating rooms, which gives rise to the need for anesthetic devices, ventilators, and respiratory monitoring systems.

UAE Anesthesia and Respiratory Devices Market Trends

A noticeable incline in the sales of anesthesia and respiratory devices is noticed in the United Arab Emirates. This is mainly due to the government's huge investment in the healthcare sector and the country's ambition to become a hub of excellent medical services. New anesthesia machines, ventilators, and respiratory monitoring systems are already getting demanded in the UAE by setting up a network of state-of-the-art hospitals, specialized clinics, and ICUs. In addition to this, the higher prevalence of respiratory diseases, mostly as a result of pollution, smoking, unhealthy living habits, and the aging of the population, is another factor that contributes to the continuous rise in demand for respiratory care devices.

Top Players in the Anesthesia and Respiratory Devices Market and Their Offerings

• Medtronic

• O2 Concepts

• Koninklijke Philips N.V.

• Drägerwerk AG & Co. KGaA

• Getinge AB.

• Smiths Group plc

• Fisher & Paykel Healthcare Limited.

• Masimo

• B. Braun Melsungen AG

• ResMed

• Shenzhen Mindray Bio-Medical Electronics Co. Ltd

• Inogen Inc.

• Caire Medical (a subsidiary of NGK Spark Plug),

• DeVilbiss Healthcare (a subsidiary of Drive Medical)

• React Health (Respiratory Product Line from Invacare Corporation)

• Teleflex Incorporated

• Nidek Medical Products Inc.

• Omron Corporation

• GE Healthcare

• Others

Key Developments

Anesthesia and respiratory devices market has experienced considerable changes in the last two years as the market players are trying to diversify their technological aspects and develop product portfolios using strategic approaches.

• In October 2025, the Carestation 850 by GE HealthCare is the company's latest anesthesia delivery system, which is all set to be compliant with the changing needs of clinical and operational staff as they work together. The current status is FDA 510(k) pending. Following the recent CE mark in European markets and Australian Therapeutic Goods approval in the Australian and New Zealand markets, the FDA 510(k) submission for Carestation 850 has been made. (https://respiratory-therapy.com/products-treatment/monitoring-treatment/therapy-devices/ge-healthcare-debuts-carestation-850-anesthesia-delivery-system/)

• In August 2025, ABM Respiratory Care is the worldwide medical technology company that is concentrating on the development of the next-generation products for respiratory care, and it has been committed to the marketing of them. The company has unveiled the launch of its cutting-edge assistant cough machine, BiWaze® Cough, in Canada through its exclusive distributor, McArthur Medical Sales Inc. BiWaze Cough is created to provide patients who have a weak or faulty cough with easier and more effective secretion clearance, being patient-friendly and at the same time making use of a high-tech method for therapy delivery. Due to McArthur Medical's in-depth knowledge of the respiratory market across Canada, clinicians and patients will have local product support, clinical training, and service available from the very first day. (https://abmrc.com/abm-respiratory-care-and-mcarthur-medical-sales-announce-nationwide-launch-of-biwaze-cough-in-canada/)

These strategic measures have enabled the companies to reinforce their competitive positions, increase the product line, boost their technological competencies, and also seize growth opportunities in the fast-growing anesthesia and respiratory devices market.

The Anesthesia and Respiratory Devices Market is segmented as follows:

By Product

• Anesthesia Devices

  • Machines

    • Workstations

    • Monitors

    • Ventilators

    • Delivery machines

      • Standalone

      • Portable

    • Disposables

      • Disposable Accessories

      • Disposable Masks

• Respiratory Devices

  • Disposables

    • Disposable Oxygen Masks

    • Resuscitators

    • Tracheostomy Tubes

    • Oxygen Cannula

  • Equipment

    • Reusable Resuscitators

    • Ventilators

      • Adult Ventilators

      • Neonatal ventilators

    • Positive Airway Pressure

      • Bi-level positive airway pressure devices

      • Continuous positive airway pressure devices

    • Nebulizers

      • Pneumatic nebulizers

      • Mesh nebulizers

      • Ultrasonic nebulizers

    • Inhalers

      • Dry powdered inhalers

      • Metered-dose inhaler

    • Humidifiers

      • Heat exchangers

      • Pass over humidifiers

      • Heat humidifiers

      • Heated wire breathing circuits

    • Oxygen Concentrators

      • Portable oxygen concentrators

      • Fixed oxygen concentrators

    • Measurement Devices

      • Spirometers

      • Pulse Oximeters

      • Capnography

      • Peak Flow Meters

By End User

• Hospitals

• Clinics

• Homecare Settings

• Ambulatory Service Centers

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America